Jennifer Batson
About Jennifer Batson
Jennifer Batson is an Associate Director of Project Biology at Exscientia, with a background in cellular and molecular biology. She has held various scientific roles, including Principal Scientist at Exonate Limited and Research Fellow at the University of Nottingham.
Current Role at Exscientia
Jennifer Batson serves as the Associate Director of Project Biology at Exscientia, a position she has held since 2022. In this role, she is involved in leading projects that integrate biology with artificial intelligence to advance drug discovery. Her work contributes to the development of innovative therapeutic solutions in the pharmaceutical industry.
Previous Experience at Exonate Limited
Before joining Exscientia, Jennifer Batson worked at Exonate Limited from 2017 to 2022. She held the position of Principal Scientist for five years, following a two-year tenure as Senior Scientist from 2015 to 2017. During her time at Exonate, she focused on research and development in the field of biology, contributing to the company's projects in drug development.
Academic Background and Education
Jennifer Batson completed her Doctor of Philosophy (PhD) in Cell Biology at the University of Bristol from 2009 to 2013. Her research during this period focused on cellular and molecular biology. Additionally, she earned a Bachelor of Science (BSc) in Biology with Industrial Experience from the University of Manchester, studying from 2005 to 2009.
Research Experience at The University of Nottingham
From 2013 to 2015, Jennifer Batson worked as a Research Fellow at The University of Nottingham. In this role, she engaged in advanced research projects that contributed to her expertise in biological sciences. Her experience in academia has provided her with a strong foundation for her subsequent roles in the industry.
Early Career at Boehringer Ingelheim
Jennifer Batson began her career as a Research Assistant at Boehringer Ingelheim in Austria from 2007 to 2008. This early experience in a global pharmaceutical company allowed her to gain practical insights into research methodologies and the drug development process.